Poseida Therapeutics Inc at Bank of America Healthcare Conference Transcript
Good afternoon, everyone. Welcome to the end of day 1 or nearing the end of day 1 of the 2022 Bank of America Healthcare Conference. Thanks for joining this session with Poseida Therapeutics. My name is Alec Stranahan; I'm Vice President and senior biotech analyst covering Poseida at BofA. And I'm pleased to be joined today by Mark Gergen, Chief Executive Officer of Poseida.
Mark, welcome.
Hey, thanks. Thanks for having us. Happy to be here.
Yeah. Yeah. So I believe Mark is going to run through just some intro comments, and then we can jump right into the Q&A.
So over to you, Mark.
Very good. Well, again, thanks for having us today. Happy to be here. Nice to get back out in the live world again. So good to be doing that. Just a word from my lawyer
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |